LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.36 | 84.90 | 334 | 5651 | 0.0591 | 0.2538 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.36 | 84.90 | 5496 | 5651 | 0.9726 | 0.9908 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.06 | 84.90 | 5364 | 5990 | 0.8954 | 0.9643 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.06 | 84.90 | 5402 | 5990 | 0.9017 | 0.9666 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.06 | 84.90 | 5911 | 5990 | 0.9867 | 0.9956 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.06 | 84.90 | 5980 | 5990 | 0.9982 | 0.9994 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.06 | 84.90 | 577 | 5990 | 0.0963 | 0.3663 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.06 | 84.90 | 5433 | 5990 | 0.9069 | 0.9684 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.06 | 84.90 | 376 | 5990 | 0.0628 | 0.2742 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.06 | 84.90 | 5813 | 5990 | 0.9703 | 0.9902 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 84.90 | 5618 | 6252 | 0.8985 | 0.9658 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 84.90 | 5659 | 6252 | 0.9051 | 0.9681 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 84.90 | 6309 | 6252 | 1.0090 | 1.0029 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 84.90 | 6370 | 6252 | 1.0188 | 1.0060 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 84.90 | 510 | 6252 | 0.0816 | 0.3352 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 84.90 | 5726 | 6252 | 0.9158 | 0.9718 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 84.90 | 438 | 6252 | 0.0701 | 0.3028 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 84.90 | 6096 | 6252 | 0.9749 | 0.9918 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.48 | 84.90 | 5904 | 6567 | 0.8989 | 0.9663 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.48 | 84.90 | 5948 | 6567 | 0.9056 | 0.9687 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.48 | 84.90 | 6574 | 6567 | 1.0009 | 1.0003 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.48 | 84.90 | 6646 | 6567 | 1.0119 | 1.0038 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.48 | 84.90 | 620 | 6567 | 0.0944 | 0.3729 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.48 | 84.90 | 5978 | 6567 | 0.9102 | 0.9702 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.48 | 84.90 | 454 | 6567 | 0.0691 | 0.3064 | MN20160318_Q02 | H15 |